Floatz logo

Plavix

Neurodegenerative Disorders

Insel Gruppe AG, University Hospital BernN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Neurodegenerative Disorders cohort.

Asset / SponsorPhaseRating
Multiple Vitamins Injection
Imperial College London
Phase 2CCC
Primepro™/ Primemsk™
Thomas Advanced Medical LLC
Phase 1/2CCC
Acetylsalicylic Acid
Insel Gruppe AG, University Hospital Bern
N/AD
Dipyridamole
Insel Gruppe AG, University Hospital Bern
N/AD

Same molecule, other indications

Plavix is also rated in:

myocardial infarctionDormant
A
Indicative ·
81 / 100
View asset →
transient ischemic attackDormant
BBB
Indicative ·
77 / 100
View asset →
peripheral arterial diseaseDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →